AHCO vs PATH · P/E 16, rev $3.26B vs P/E 19, rev $1.61B
Adapthealth Corp (AHCO) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Adapthealth Corp (AHCO) is a medical devices company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported AHCO revenue for 2024-12-31 was $3.26B. Net income was $94.8M. Revenue was up 1.9% from 2023-12-31 to 2024-12-31. AHCO currently screens at market cap $1.26B and trailing P/E 16.1.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
AHCO currently screens at market cap $1.26B and trailing P/E 16.1. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the AHCO and PATH stock pages for the full models.
Not investment advice.